A. Isik Et Al. , "The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia," TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, pp.328-330, 2013
Isik, A. Et Al. 2013. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia. TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3 , 328-330.
Isik, A., ELİAÇIK, E., HAZNEDAROĞLU, İ. C., AKSU, S., SAYINALP, N., BÜYÜKAŞIK, Y., ... GÖKER, H.(2013). The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia. TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, 328-330.
Isik, Ayse Et Al. "The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia," TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, 328-330, 2013
Isik, Ayse Et Al. "The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia." TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, pp.328-330, 2013
Isik, A. Et Al. (2013) . "The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia." TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, pp.328-330.
@article{article, author={Ayse Isik Et Al. }, title={The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2013, pages={328-330} }